Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
8,162,306
-
Share change
-
+8,162,306
-
Total reported value
-
$141,208,000
-
Price per share
-
$17.30
-
Number of holders
-
27
-
Value change
-
+$141,208,000
-
Number of buys
-
27
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q2 2018
As of 30 Jun 2018,
Kezar Life Sciences Inc - COMMON-STOCK (KZR) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,162,306 shares.
The largest 10 holders included
Cormorant Asset Management, LP, FMR LLC, EcoR1 Capital, LLC, COWEN INC., Omega Fund Management, LLC, VICTORY CAPITAL MANAGEMENT INC, FRANKLIN RESOURCES INC, FRAZIER MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., and Marshall Wace North America L.P..
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.